Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study

Dejan B. Budimirovic, Kelli C. Dominick, Lidia V. Gabis, Maxwell Adams, Mathews Adera, Linda Huang, Pamela Ventola, Nicole R. Tartaglia, Elizabeth Berry-Kravis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study'. Together they form a unique fingerprint.

Medicine & Life Sciences